Literature DB >> 35244697

Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Nonalcoholic Fatty Liver Disease in Middle Age.

Haobin Zhou1, Xianghui Zeng1, Yuting Xue1, Xiao Wang1, Shenrong Liu2, Zongyuan Zhu3, Zichao Luo1, Zhuang Ma1, Hao Zhang1, Qiong Zhan1, Yujia Bai1, Xingfu Huang1, Qingchun Zeng1, Hao Ren4, Dingli Xu1.   

Abstract

CONTEXT: Diabetes has a bidirectional association with nonalcoholic fatty liver disease (NAFLD) and increases the risk of cirrhosis and related complications.
OBJECTIVE: To investigate the association between visit-to-visit fasting glucose (FG) variability in early adulthood and NAFLD in middle age.
METHODS: This prospective cohort study included 2467 Black and White adults aged 18 to 30 years at baseline (1985-1986) who were followed over 25 years in the Coronary Artery Risk Development in Young Adults Study. FG variability measures included coefficient of variation about the mean FG (CV-FG), the SD of FG (SD-FG), and the average real variability of FG (ARV-FG) across 25 years (year 0, 7, 10, 15, 20, and 25 examinations). NAFLD was defined as liver attenuation ≤ 40 Hounsfield units on computed tomography scan at year 25 examination after excluding other causes of hepatic steatosis.
RESULTS: Of the 2467 participants, 241 (9.8%) had NAFLD at year 25. In multivariate analysis, the odds ratio for NAFLD was 2.80 (95% CI, 1.69-4.64; P trend < 0.001) for the fourth quartile vs first quartile of CV-FG after adjusting for confounding variables, including mean FG. Similar results were observed for SD-FG and ARV-FG.
CONCLUSION: Greater visit-to-visit FG variability in early adulthood was associated with higher risk of NAFLD in middle age independent of mean FG level. FG variability may help identify individuals at high risk for NAFLD.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  FG variability; NAFLD; mean FG

Mesh:

Substances:

Year:  2022        PMID: 35244697      PMCID: PMC9272423          DOI: 10.1210/clinem/dgac122

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   6.134


  47 in total

Review 1.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

2.  Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.

Authors:  Jochem R van Werven; Hendrik A Marsman; Aart J Nederveen; Nico J Smits; Fiebo J ten Kate; Thomas M van Gulik; Jaap Stoker
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

Review 3.  Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

Authors:  K H Williams; N A Shackel; M D Gorrell; S V McLennan; S M Twigg
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

4.  High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.

Authors:  Stefano Ciardullo; Tommaso Monti; Gianluca Perseghin
Journal:  Diabetes Care       Date:  2020-12-10       Impact factor: 19.112

Review 5.  Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.

Authors:  Per-Henrik Groop; Carol Forsblom; Merlin C Thomas
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-12

6.  Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.

Authors:  Ju Dong Yang; Fowsiyo Ahmed; Kristin C Mara; Benyam D Addissie; Alina M Allen; Gregory J Gores; Lewis R Roberts
Journal:  Hepatology       Date:  2019-10-21       Impact factor: 17.425

Review 7.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

Review 8.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

Review 9.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

10.  Association Between Fasting Glucose Variability in Young Adulthood and the Progression of Coronary Artery Calcification in Middle Age.

Authors:  Weijing Feng; Zhibin Li; Wenjie Guo; Xianglin Fan; Feiran Zhou; Kun Zhang; Caiwen Ou; Feifei Huang; Minsheng Chen
Journal:  Diabetes Care       Date:  2020-07-30       Impact factor: 17.152

View more
  1 in total

1.  Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Nonalcoholic Fatty Liver Disease in Middle Age.

Authors:  Haobin Zhou; Xianghui Zeng; Yuting Xue; Xiao Wang; Shenrong Liu; Zongyuan Zhu; Zichao Luo; Zhuang Ma; Hao Zhang; Qiong Zhan; Yujia Bai; Xingfu Huang; Qingchun Zeng; Hao Ren; Dingli Xu
Journal:  J Clin Endocrinol Metab       Date:  2022-05-17       Impact factor: 6.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.